Skip to main content

Table 4 GAF data from the original studies

From: Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)

Patients with baseline assessment

Patients from Canadian study (n = 169)

Patients from German study (n = 238)

p-value

GAF at baseline, mean (SD)

48.7 (12.6)

46.9 (13.9)

 

Patients with baseline and at least one post-baseline assessment

Patients from Canadian NIS (n = 168)

Patients from German NIS (n = 228)

 

GAF at baseline, mean (SD)

48.7 (12.6)

47.0 (13.9)

0.22a

GAF at month 6, mean (SD)

58.0 (13.8)

60.5 (17.1)

0.04a

Responders with improvement by at least 10 points, n (%)

75 (44.6)

129 (56.6)

0.02b

  1. GAF Global Assessment of Functioning, SD standard deviation
  2. aWilcoxon Two-sample test; bFisher’s exact test